FIZZ1 promotes airway remodeling through the PI3K/Akt signaling pathway in asthma

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1265-1270

  Wang, Junfei ^a   Li, Fei ^a,b   Yang, Mengmeng ^a   Wu, Jinxiang ^a   Zhao, Jiping ^a   Gong, Wenbin ^a   Liu, Wen ^c   Bi, Wenxiang ^d   Dong, Liang ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEOPLE S HOSPITAL OF RIZHAO   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Airway remodeling; Asthma; Epithelial mesenchymal transition; Found in inflammatory zone 1; Phosphoinositide 3 kinase protein kinase B signaling pathway

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; FOUND IN INFLAMMATORY ZONE 1 PROTEIN; MESSENGER RNA; OVALBUMIN; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; ENZYME INDUCTION; EPITHELIAL MESENCHYMAL TRANSITION; ESCHERICHIA COLI; FEMALE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84896862630     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1580     Document Type: Article

References (22)

1. Nakagome K and Nagata M: Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx38: 555-563, 2011.
2. HoltageST: Pathogenesis of asthma. Clin Exp Allergy38: 872-897, 2008.
3. Sumi Y and Hamid Q: Airway remodeling in asthma. Allergol Int56: 341-348, 2007.
4. Holgate ST, Davies DE, Lackie PM, Wilson SJ, PuddicombeSM and Lordan JL: Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol105: 193-204, 2000.
5. Hackett TL: Epithelial-mesemchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol12: 53-59, 2012.
6. Hackett TL, Warner SM, Stefanowicz D, et al: Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med180: 122-133, 2009.
7. Folli C, Descalzi D, Scordamaglia F, Riccio AM, Galamero C and Canonica GW: New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol8: 367-375, 2008.
8. Holcomb IN, Kabakoff RC, Chan B, et al: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J19: 4046-4055, 2000.
9. Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC and JohnsRA: Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol291: L1159-L1168, 2006.
10. Dong L, Wang SJ, Camoretti-Mercado B, Li HJ, Chen M and BiWX: FIZZ1 plays a crucial role in early stage airway remodeling of OVA-induced asthma. JAsthma45: 648-653, 2008.
11. Huber P, Menif K and Jouvet P: Acute severe asthma in pediatric resuscitation. The French Study Group on Pediatric Resuscitation. Arch Pediatr 1: 346-349, 1994 (In French).
12. Cho JY: Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic. Korean J Intern Med26: 367-383, 2011.
13. Halwani R, Al-Muhsen S and Hamid Q: Airway remodeling in asthma. Curr Opin Pharmacol 10: 236-245, 2010.
14. Yadav UC, Naura AS, Aguilera-Aguirre L, et al: Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice. PLoS One8: e57442, 2013.
15. Lee KS, Lee HK, Hayflick JS, Lee YC and Puri KD: Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J20: 455-465, 2006.
16. Duan W, Aguinaldo Datiles AM, Leung BP, VlahosCJ and WongWS: An anti-inflammatory role for a phophoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol5: 495-502, 2005.
17. Lim DH, Cho JY, Song DJ, Lee SY, Miller M and BroideDH: PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. AmJ Physiol Lung Cell Mol Physiol296: L210-L219, 2009.
18. Medina-Tato DA, Ward SG and Watson ML: Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology121: 448-461, 2007.
19. Lee KS, Kim SR, Park SJ, et al: Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol Pharmacol69: 1829-1839, 2006.
20. Lee YC: The role of PTEN in allergic inflammation. Arch Immunol Ther Exp (Warsz) 52: 250-254, 2004.
21. Kwark YG, Song CH, Yi HK, Hwang PH, Kim JS, LeeKS and Lee YC: Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest111: 1083-1092, 2003.
22. Lan H, Zhong H, Gao Y, et al: The PTEN tumor suppressor inhibits human airway smooth muscle cell migration. Int J Mol Med26: 893-899, 2010.